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A cDNA encoding the acidic eye-derived growth factor (EDGF II) similar to the acidic fibroblast growth factor (aFGF), 
a potent cell mitogen, has been isolated from a bovine retinal cDNA library. The cDNA, 4.1 kb in size, has a sequence 
coding for the 155 amino acids of bovine aFGF, and shows similarity with human aFGF (87% identity). The coding 
sequence is flanked by a 5’-untranslated region f 0.8 kb and a 3’untranslated end of 3.0 kb. Northern blot analysis 
of bovine brain and retina poly(A’) RNAs showed the existence of four aFGF mRNA species. Two of these species 
are 9.9 and 6.0 kb in size, not abundant and could represent premessengers. The other two species, 4.2 and 2.5 kb, are 
abundant. 
Fibroblast growth factor; Retina; mRNA, Nucleotide sequence; (Bovine, Brain) 
1. INTRODUCTION 
Growth factor activity was first identified in 
adult bovine retina in 1978 [l]. This mitogenic ac- 
tivity is also present in other ocular tissues such as 
iris, vitreous body and pigmented epithelium from 
bovine and chick embryo [2,3]. It was designated 
as eye-derived growth factor (EDGF). Affinity 
chromatography on heparin-Sepharose has allow- 
ed the purification of two retinal growth factors 
(EDGF I, EDGF II) to homogeneity. Biochemical 
and immunological techniques have shown that 
EDGF I and EDGF II are similar to the basic and 
acidic fibroblast growth factors (bFGF and aFGF), 
respectively [4]. bFGF originally purified from 
bovine brain has 146 amino acid residues and 
aFGF 140 [5,6]. The acidic and basic FGFs are 
closely related: 55% of their amino acid sequence 
is identical. These two FGFs as well as the retinal 
aFGF and bFGF forms are potent mitogens for a 
wide variety of cells of both mesodermal and ec- 
todermal embryonic origin (for a review see [7]). 
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The biological activity of aFGF is potentiated by 
the glycosaminoglycan heparin [8,9]. 
Previous results have indicated that FGFs are in- 
volved in eye development and in vision. Basic 
and, to a lesser extent, acidic FGFs specifically 
bind to basement membranes of the eye [lo]. We 
have recently reported that EDGF II is present in 
the dark-adapted rod outer segments (ROS) from 
bovine retina [l 11. In newt, the addition of EDGF 
II to the dorsal iris in culture stimulates lens 
regeneration [12]. These data suggest that aFGF 
could be involved in the photoreceptor cell 
biology. Most tissues so far investigated contain 
several forms of bFGF differing in their amino- 
terminal ends [7,13,14]. Similarly, an amino- 
terminally truncated aFGF which lacks six ter- 
minal residues has been purified from bovine brain 
[15]. More recently an amino-terminally blocked 
form of aFGF with 155 residues has been isolated 
from bovine brain [16]. Using specific cDNA 
probes, a 7.0 kb and a 3.7 kb mRNA coding for 
bFGF [17] have been detected in the bovine 
hypothalamus, while a cDNA clone coding for 
human aFGF hybridized to a 4.8 kb mRNA in the 
human brain stem and glioma cells [ 18,191. 
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However, it is not clear if the different forms of 
bFGF and aFGF have different biological effects. 
In order to investigate the effect of aFGFs in 
retina, we isolated a cDNA clone coding for the 
retinal form of aFGF. This probe specifically 
hybridizes to four different mRNAs from bovine 
brain and retina. 
2. MATERIALS AND METHODS 
2.1. RNA isolation 
RNA containing aFGF messengers was isolated from bovine 
brain and retina, and from a confluent murine neuroblastoma 
cell line (N 115) grown in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 5% fetal calf serum. Total RNA 
was isolated with 4 M guanidinium isothiocyanate and 1 M 
2-mercaptoethanol according to standard procedures [20,21]. 
Poly(A+) RNA was prepared by two oligo(dT)-cellulose affinity 
chromatographies (Collaborative Research) [22]. 
2.2. Synthesis of cDNA library 
The poly(A+) RNA isolated from bovine retina was used to 
construct a cDNA library [23]. Briefly, the first strand cDNA 
was primed with oligo(dT) and synthesized using reverse 
transcriptase. The second strand was synthesized with a com- 
bination of E. coli RNase H and DNA polymerase 1. After ad- 
dition of EcoRI linkers, the double-stranded cDNAs were 
ligated into the vector hgtll. The cDNA library (7 x lo6 pla- 
ques) was established in E. coli Y 1090 1241. 
2.3. Screening of the library 
A 42-mer oligonucleotide probe was derived from the aFGF 
genomic clone as previously described [17]. It corresponds to 
the residues 24-37 of the amino acid sequence. This 32P- 
labelled probe was used to screen 2 x lo6 recombinant phages. 
Hybridization was performed in 6 x SSC, 50% formamide, 
10 x Denhardt’s solution, 0.1% SDS and lOO~g/ml salmon 
sperm DNA at 42°C. Filters were washed two times 20 min in 
0.1 x SSC, 0.1% SDS at 60°C. Six clones giving a positive 
signal were further characterized by restriction mapping and 
Southern analysis. This finally led to the selection of one clone 
(11.32.12). 
2.4. Subcloning and sequencing 
The insert of clone 11.32.12 was excised with EcoRI from 
hgtl 1 vector and restricted with XbaI. The fragments EcoRI- 
XbaI were made blunt ended with the Klenow fragment of the 
DNA polymerase I and inserted in both directions in Ml3 mp18 
and mp19 vectors. Exonuclease III digestion [25] was used to in- 
troduce progressive deletions into the cDNA sequence. The se- 
quencing was carried out by the dideoxy chain termination 
method [26]. 
2.5. Northern hybridization 
5-20 gg of poly(A+) RNA purified from brain and retina was 
electrophoresed on a horizontal formaldehyde agarose gel 
(l%), transferred to a nitrocellulose membrane [27], and 
hybridized to nick-translated, “P-1abelled DNA fragments cor- 
42 
responding to different regions of the cDNA insert. Hybridiza- 
tions were carried out as described above, the filters were 
washed in 0.1 x SSC, 0.1% SDS at 50°C and autoradiographed 
for different lengths of time. Ribosomal RNA from brain and 
retina were used as controls. 
2.6. Probes 
A 250 bp bovine genomic clone coding for the first 56 amino 
acids of aFGF (PCB), and a 1.4 kb cDNA specific for bovine 
bFGF [17] were obtained from J.C. Fiddes and J. Abraham. 
3. RESULTS 
3.1. Screening of the cDNA library 
A cDNA library constructed from bovine retina 
poly(A+) RNA in hgtl 1 vector was screened with a 
synthetic 42-mer oligonucleotide probe. From 2 x 
lo6 clones only one cDNA clone (11.32.12) was 
characterized. Digestion of this clone with EcoRI 
resulted in a 4.1 kb insert. The cDNA contained 
0.8 and 3 kb untranslated regions at the 3’ - and 
5 ‘-ends and had a single open reading frame 
coding for the 155 residues of bovine aFGF. The 
partial restriction map and the sequence of the 465 
nucleotides of the coding region are shown 
(fig.lA,B). The protein sequence of the aFGF 
deduced from this sequence coincides well with 
that of the human aFGF. The comparison of the 
nucleotides from human and bovine coding se- 
quences of aFGF shows a 87% sequence similarity. 
As described for human aFGF, the 155 amino 
acids coding for the bovine aFGF are flanked by 
stop codons indicating that aFGF is not synthe- 
sized as a precursor. 
3.2. RNA analysis by Northern hybridization 
To examine the expression of aFGF and bFGF 
mRNAs in bovine brain and retina, we hybridized 
lo-20 pug poly(A+) RNAs to acidic (fig.2A) and 
basic (fig.2B) cDNAs. The two tissues contained 
four aFGF mRNA species (fig.2A). The 9.9 and 
the 6.0 kb transcripts were only detectable in 20 pg 
poly(A+) RNA. In both tissues the 4.2 kb and 
2.5 kb transcripts were more abundant than ex- 
pected since the specific oligonucleotide probe 
yielded only one positive clone out of 2 x lo6 pla- 
ques which were screened. In the two tissues, the 
4.2 kb mRNA was the most abundant of the four 
transcripts. No aFGF mRNAs were visualized in 
10 pg poly(A+) RNA isolated from the 
neuroblastoma N 115 cell line. When using a bFGF 
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Fig.1. (A) Partial restriction map of the 4100 bp cDNA coding for bovine acidic FGF. E, EcoRI; B, BarnHI; P, WI; S, SphI; X, 
XbuI; K, KpnI. Positions of the initiator (ATG) and terminator (TAA) codons are indicated. bp, base pairs. Some Xba additional 
sites may have been protected by methylation and may not have been detected. (B) Nucleotide sequence and deduced amino acids of 
the bovine acidic FGF. The 2.7 kb restriction fragment EcoRI-XbaI was subcloned into Ml3 mp19 in both directions. The subclones 
were treated with exonuclease III for different periods of time, and the bovine acidic FGF open reading frame and the 5’- and 
3’-flanking regions were sequenced by the chain termination method as described in section 2. The solid box corresponds to the 
sequenced region. 
probe, a 7.0 kb and a 3.7 kb mRNAs were 
detected in retina and in brain (fig.2B). With 
similar hybridization conditions, the intensity of 
the signal obtained with the bFGF probe even after 
7 days of exposure is less intense than the one ob- 
tained after 2 days of exposure with the aFGF pro- 
be, suggesting that in these tissues the bFGF is less 
abundant than aFGF. 
We probed the same RNA blots with DNA 
fragments containing the 800 nucleotides of the 
5 ’ -untranslated region (EcoRI-BarnHI fragment) 
or the 600 nucleotides of the 3 ‘-untranslated 
region (EcoRI-KpnI fragment, see fig.lA). A 
genomic clone (PCB) containing the region coding 
for the first 56 amino acids of bovine aFGF [17] 
was also used in Northern blot analysis. 
As seen in fig.3, the 4.2 kb mRNA hybridized 
with all three probes. The 2.5 kb mRNA hybrid- 
ized to the full-length probe and to the probe con- 
taining the 3 ‘-untranslated region in both tissues 
(brain, retina). It is worth noting that in contrast 
to the hybridization profile corresponding to the 
full-length cDNA probe, the 2.5 kb mRNA was 
more intensely labelled than the 4.2 kb mRNA 
when probed with the 3 ’ -end DNA fragment. This 
mRNA species was not detected by the 
43 
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Fig.2. Northern blot analysis of poly(A+) mRNA derived from 
bovine retina or bovine brain and N 115 murine neuroblastoma 
cell line. Polyadenylated mRNAs were prepared from: bovine 
retina (Al, 10,~~; A2 and Bl, 20/c&; bovine brain (A3, 10/g; 
B2, 20~8); N 115 neuroblastoma cell line (A4, 10 gg). They 
were analyzed for the presence of aPGF (A) and bFGF (B) gene 
transcripts with cDNA probes. RNAs were hybridized with (A) 
full-length bovine aFGF cDNA clone or (B) 1.4 kb EcoRI 
fragment from bovine cDNA clone coding for bFGF, as 
described in section 2. The arrows indicate the “P-1abelled 
EZindIII restriction fragments of lambda DNA. 
5 ‘-untranslated region specific probe or by the 
PCB probe. A similar result was obtained when a 
BarnHI-SphI fragment containing the entire 
coding sequence or a SphI-SphI fragment were 
used (not shown). The 5 ‘-untranslated region 
specific probe hybridized only to the 4.2 kb, the 
6.0 kb and the 9.9 kb mRNAs in brain. In the 
retina, the 6.0 kb was clearly detected while the 
9.9 kb mRNA barely hybridized to this probe. 
This apparent discrepancy between the two 
hybridization profiles corresponding to brain and 
retina RNAs probably reflects an underestimation 
A 
Fig.3. Northern blot analysis of 20 /cg poly(A+) mRNA derived 
from bovine retina (A) and bovine brain (B). Polyadenylated 
mRNAs were analyzed by hybridization as described in section 
2 with full-length bovine retina aFGF cDNA clone (lane 1), 
aFGF (250 bp) bovine genomic clone (lane 2), Kpnl-EcoRI 
restriction fragment from the 3’-end of bovine retina aFGF 
cDNA clone (lane 3) and BumHI-EcoRI restriction fragment 
from the 5 ‘-end of bovine retina aPGF cDNA clone (lane 4). 
Arrows indicate the ‘*P-1abelled Hind111 restriction fragments 
of lambda DNA. 
of the amount of the retina poly(A+) RNA loaded 
on the gel as suggested by fig.2A. 
4. DISCUSSION AND CONCLUSION 
Previous studies indicate that there is a single 
gene on chromosome 5 encoding human aFGF [28] 
and there is considerable vidence suggesting a role 
for this mitogen in cell proliferation, wound heal- 
ing, neovascularization associated with the rapid 
growth of solid tumor and induction of mesoderm 
in vertebrate development [29]. The isolation from 
brain of a 250 bp genomic clone coding for bovine 
aFGF and a 2.2 kb cDNA clone specific for human 
aFGF has been reported [ 17,181. Acidic FGF has 
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been purified from a large number of tissues (see 
review 171) including bovine retina [ 1,4]. In the pre- 
sent study we isolated a 4.1 kb cDNA clone from 
a cDNA library constructed from retina poly(A’) 
RNA. This is the first report of a cDNA clone con- 
taining the 465 nucleotides coding for the 155 
amino acids of bovine aFGF. The amino acid se- 
quence deduced from the nucleotide sequence 
agrees well with the reported amino acid sequence 
of the bovine and human aFGFs. The nucleotide 
sequence indicates that the amino acid residue of 
bovine aFGF at position 45 is Gln rather than Phe 
as previously reported [6,30]. The open reading 
frame is preceded by 800 bp at the 5 ‘-end and is 
followed by untranslated region of about 3OBO bp. 
The presence of such a long untranslated region 
specially at the 3’-end suggests that this region 
could be implicated in the translational control of 
aFGF expression as is the case with other growth 
factors or hormones [31]. 
The isolation of an aFGF cDNA clone from a 
retinal library indicates that the aFGF present in 
the retina is in fact synthesized by this tissue. In 
situ hybridization experiments are in progress to 
determine which specific cells of the retina express 
aFGF mRNA [32]. In all previous reports using 
either a bovine genomic clone or a human cDNA 
clone coding for aFGF only one transcript of 
4.8 kb was described in human stem cells and in 
glioma cells [ 17,181. More recently two transcripts 
of 3.3 kb and 2.8 kb were detected in a human 
smooth muscle cell line [33]. Using our 4.1 kb long 
cDNA clone we show the presence of four dif- 
ferent size mRNAs in two different neural tissues: 
the brain and the retina. These four transcripts are 
present in different amounts: the largest ones (the 
9.9 and 6.0 kb) are barely detected in 20pg 
poly(A+) RNA and possibly represent he nuclear 
precursors of the aFGF mRNAs. The 4.2 kb 
transcript gives the strongest hybridization signal 
when RNAs from retina were probed with the full- 
length cDNA. This 4.2 kb mRNA probably cor- 
responds to the one previously described. In fact, 
this transcript is the only one which hybridized to 
the bovine genomic aFGF clone which encodes the 
first 56 amino acids of bovine aFGF. Northern 
analysis of the four messages which hybridized to 
the aFGF clone indicates that they differ in their 
5 ’ - and 3 ’ -untranslated regions. Of special interest 
is the 2.5 kb transcript, which does not hybridize 
to the PCB probe. We have also detected no 
hybridization signal at 2.5 kb when a cDNA frag- 
ment that spans only the coding sequence (BarnHI- 
SphI fragment) was used as a probe. These results 
suggest that the 2.5 kb transcript does not contain 
any aFGF coding sequences, and may code for a 
different peptide. 
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NOTE ADDED IN PROOF 
Since this paper was submitted the full sequence of the cDNA has been determined and is accessible in 
the EMBL library under the number x13221. 
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